TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC, Higgins C, Ong CW, Irwin GW, Boyle D, McArt DG, McCloskey K, Buckley NE, Crawford NT, Thiagarajan L, Murray JT, Kennedy RD, Mulligan KA, Harkin DP, Waugh DJ, Scott CJ, Salto-Tellez M, Williams R, Mullan PB.
D'Costa ZC, et al.
Oncotarget. 2014 Mar 30;5(6):1609-20. doi: 10.18632/oncotarget.1707.
Oncotarget. 2014.
PMID: 24742492
Free PMC article.